Systematic Review
Accepted on 13 Feb 2026
Neoadjuvant Chemoradiotherapy With or Without PD-1 Inhibitors in MMR‑Proficient Non‑Metastatic Rectal Cancer: A Meta-Analysis of Randomized Controlled Trials
in Cancer Immunity and Immunotherapy
Systematic Review
Accepted on 13 Feb 2026
in Cancer Immunity and Immunotherapy
Editorial
Accepted on 13 Feb 2026
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 13 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 13 Feb 2026
in Cancer Immunity and Immunotherapy
Correction
Published on 13 Feb 2026
in Cancer Immunity and Immunotherapy
Review
Published on 13 Feb 2026
in Cancer Immunity and Immunotherapy
Case Report
Published on 13 Feb 2026
in Cancer Immunity and Immunotherapy
Case Report
Published on 13 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Published on 13 Feb 2026
in Cancer Immunity and Immunotherapy
Case Report
Published on 13 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Published on 13 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Published on 13 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Review
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Review
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Systematic Review
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy
Review
Accepted on 12 Feb 2026
in Cancer Immunity and Immunotherapy